Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel E Sobel

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Medical Research and Opinion|May 30, 2008
Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular eventsRachel E Sobel, Robert F Reynolds
Drug Safety|October 11, 2018
Real World Evidence: Time for a Switch?Rachel E Sobel, Andrew Bate, Robert F Reynolds
Arthritis Care & Research|June 11, 2010
Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registryMeredith Y Smith, Rachel E Sobel, Carol A Wallace
International Journal of Clinical Pharmacy|April 5, 2022
A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect<sup>®</sup> additional risk minimisation measuresJoanna Lem, Janine Collins, Terry Maguire, et al.
Drug Safety|August 2, 2019
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis ToolRachel E Sobel, William Blackwell, David M Fram, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional SurveyJoanna Lem, Muhammad Younus, Jalal A Aram, et al.
BMC Musculoskeletal Disorders|June 15, 2024
Risk of carpal tunnel syndrome among patients with osteoarthritis: a US population-based studyShuang Chen, Tina Ho, Julius Asubonteng, et al.
Pharmacoepidemiology and Drug Safety|February 25, 2016
Current needs in pediatric pharmacoepidemiologyTamar Lasky, Al Artaman, Angela S Czaja, et al.
Pharmacoepidemiology and Drug Safety|February 3, 2018
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic toolsRachel E Sobel, Andrew Bate, James Marshall, et al.
International Journal of Medical Informatics|January 5, 2016
Computer-assisted expert case definition in electronic health recordsAlexander M Walker, Xiaofeng Zhou, Ashwin N Ananthakrishnan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|May 30, 2008
Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular eventsRachel E Sobel, Robert F Reynolds
Drug Safety|October 11, 2018
Real World Evidence: Time for a Switch?Rachel E Sobel, Andrew Bate, Robert F Reynolds
Arthritis Care & Research|June 11, 2010
Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registryMeredith Y Smith, Rachel E Sobel, Carol A Wallace
International Journal of Clinical Pharmacy|April 5, 2022
A web-based survey of UK pharmacists to assess the effectiveness of Viagra Connect<sup>®</sup> additional risk minimisation measuresJoanna Lem, Janine Collins, Terry Maguire, et al.
Drug Safety|August 2, 2019
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis ToolRachel E Sobel, William Blackwell, David M Fram, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional SurveyJoanna Lem, Muhammad Younus, Jalal A Aram, et al.
BMC Musculoskeletal Disorders|June 15, 2024
Risk of carpal tunnel syndrome among patients with osteoarthritis: a US population-based studyShuang Chen, Tina Ho, Julius Asubonteng, et al.
Pharmacoepidemiology and Drug Safety|February 25, 2016
Current needs in pediatric pharmacoepidemiologyTamar Lasky, Al Artaman, Angela S Czaja, et al.
Pharmacoepidemiology and Drug Safety|February 3, 2018
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic toolsRachel E Sobel, Andrew Bate, James Marshall, et al.
International Journal of Medical Informatics|January 5, 2016
Computer-assisted expert case definition in electronic health recordsAlexander M Walker, Xiaofeng Zhou, Ashwin N Ananthakrishnan, et al.
Pageof 3